In-vitro fertilization is a process of fertilization, used to treat fertility or genetic problems and assist with conception of child. In this process, an egg is combined with the sperm and fertilized in a lab. It is the most effective form of assisted reproductive technology. The success rate of the procedure depends on numerous factors including maternal age, cause of infertility, embryo status, reproductive history and lifestyle factors. The global In-vitro fertilization market is primarily driven by increasing incidences of infertility among male and female across the globe, decreasing fertility rate, rising male infertility, rise in consumption of alcohol and cigarettes and increasing awareness about in-vitro fertilization process and technologies. Additionally, increasing government initiatives and flexible government regulation to promote IVF treatments are backing the grow of In-Vitro fertilization market. However, factors hindering the growth of in-vitro fertilization market growth includes excessive cost associated with the treatment and change in government regulation with respect to various countries. The report analyses the global in-vitro fertilization market based on product into reagents and equipment’s. The reagents segment is further categorized into embryo culture media, cryopreservation media, sperm processing media and ovum processing media. Moreover, equipment segment is bifurcated into imaging system, sperm separation system, cabinet, ovum aspiration pump, Incubators, micro manipulation system, gas analyser, laser system, accessories, cryosystems, anti-vibration tables and witness system. Embryo culture media dominated the IVF reagents market in 2017 and is also projected to grow at the highest pace during the forecast period. The large share of this segment is attributed to rising awareness of infertility treatment and diagnosis globally. Based on the cycle type, the global in-vitro fertilization market is segmented into fresh donor IVF cycle, fresh non-donor IVF cycle, frozen donor IVF Cycle and frozen non-donor IVF cycle. In 2017, the fresh non-donor segment is expected to account for the largest share in the global in-vitro fertilization market during the forecast period, owing to the fact that it is the most common and easy method in an in-vitro fertilization process. Based on end user, the in-vitro fertilization market is categorized into fertility clinics and surgical centres, hospital and research laboratories and cryobanks. The hospitals segment accounted for the largest share of the IVD market in 2017. The largest share of the market is attributed to full range of services provided in the hospitals including various diagnostics test and surging number of private hospitals. By geography, the global in-vitro fertilization market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America comprises United States, Canada and Mexico whereas Europe would primarily cover Germany, France, UK, Italy and Rest of Europe. The key countries included under Asia Pacific are China, Japan, India, Australia, and Rest of Asia Pacific. In Latin America, Brazil, Argentina, and Rest of Latin America are the key countries whereas in Middle East & Africa, South Africa and Rest of MEA are the key countries covered in the report. The Asia Pacific dominated the global In-Vitro fertilization in 2017. Asia Pacific is followed by Europe In-Vitro fertilization market. The key driving factors leading to the considerable growth includes, improved surrogacy laws, increasing healthcare expenditure and growing infertility rate due to changing lifestyle. Some of the key participants of the global in-vitro fertilization market are Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), and QIAGEN (Germany) The in-vitro fertilization market players are adopting various strategies including technological advancement in terms of cost-effectiveness and portability, research & development, mergers and agreements to reinforce their position in the global market.
Why to buy this report: